These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17444078)

  • 21. [Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(4 Pt 1):306-12. PubMed ID: 14615700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cholesterol in treatment-resistant depression.
    Papakostas GI; Petersen T; Sonawalla SB; Merens W; Iosifescu DV; Alpert JE; Fava M; Nierenberg AA
    Neuropsychobiology; 2003; 47(3):146-51. PubMed ID: 12759558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging methods for treatment resistant depression. A systematic review.
    Ruhé HG; van Rooijen G; Spijker J; Peeters FP; Schene AH
    J Affect Disord; 2012 Mar; 137(1-3):35-45. PubMed ID: 21435727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining treatment-resistant depression.
    Gaynes BN; Lux L; Gartlehner G; Asher G; Forman-Hoffman V; Green J; Boland E; Weber RP; Randolph C; Bann C; Coker-Schwimmer E; Viswanathan M; Lohr KN
    Depress Anxiety; 2020 Feb; 37(2):134-145. PubMed ID: 31638723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic options in treatment-resistant depression.
    Vieta E; Colom F
    Ann Med; 2011 Nov; 43(7):512-30. PubMed ID: 21623700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axis III disorders in treatment-resistant major depressive disorder.
    Papakostas GI; Petersen T; Iosifescu DV; Roffi PA; Alpert JE; Rosenbaum JF; Fava M; Nierenberg AA
    Psychiatry Res; 2003 May; 118(2):183-8. PubMed ID: 12798983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment.
    Rybak YE; Lai KSP; Ramasubbu R; Vila-Rodriguez F; Blumberger DM; Chan P; Delva N; Giacobbe P; Gosselin C; Kennedy SH; Iskandar H; McInerney S; Ravitz P; Sharma V; Zaretsky A; Burhan AM
    Depress Anxiety; 2021 Apr; 38(4):456-467. PubMed ID: 33528865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-resistant depression: critique of current approaches.
    Wijeratne C; Sachdev P
    Aust N Z J Psychiatry; 2008 Sep; 42(9):751-62. PubMed ID: 18696279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
    Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
    Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.
    Yoshida K; Sugawara Y; Higuchi H
    Pharmacopsychiatry; 2006 May; 39(3):114. PubMed ID: 16721702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tricyclic antidepressants in prepubertal depressed children: review of the literature.
    Weller RA; Weller EB
    Hillside J Clin Psychiatry; 1986; 8(1):46-55. PubMed ID: 3527932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.
    McIntyre RS; Filteau MJ; Martin L; Patry S; Carvalho A; Cha DS; Barakat M; Miguelez M
    J Affect Disord; 2014 Mar; 156():1-7. PubMed ID: 24314926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is treatment-resistant depression a unique subtype of depression?
    Fagiolini A; Kupfer DJ
    Biol Psychiatry; 2003 Apr; 53(8):640-8. PubMed ID: 12706950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis.
    Newton-Howes G; Tyrer P; Johnson T; Mulder R; Kool S; Dekker J; Schoevers R
    J Pers Disord; 2014 Aug; 28(4):577-93. PubMed ID: 24256103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How different definition criteria may predict clinical outcome in treatment resistant depression: Results from a prospective real-world study.
    Zanardi R; Carminati M; Attanasio F; Fazio V; Maccario M; Colombo C
    Psychiatry Res; 2024 Apr; 334():115818. PubMed ID: 38422869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.
    Feske U; Mulsant BH; Pilkonis PA; Soloff P; Dolata D; Sackeim HA; Haskett RF
    Am J Psychiatry; 2004 Nov; 161(11):2073-80. PubMed ID: 15514409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.